Share Price and Basic Stock Data
Last Updated: December 24, 2025, 8:37 pm
| PEG Ratio | -1.76 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chemcon Speciality Chemicals Ltd operates in the specialty chemicals sector, focusing on producing a variety of chemical products. The company reported sales of ₹303 Cr for the fiscal year ending March 2023, a notable increase from ₹257 Cr in March 2022. However, sales are projected to decline in the following fiscal year, with reported figures of ₹267 Cr for March 2024 and ₹207 Cr for March 2025. Quarterly sales data indicates a fluctuation in performance, with the highest quarterly sales of ₹89.41 Cr recorded in June 2022, followed by a downward trend in subsequent quarters. The most recent sales figure for June 2023 stood at ₹79.33 Cr, indicating a slight recovery from the previous quarter’s ₹79.08 Cr. Overall, despite the recent sales volatility, the company has shown significant growth from earlier years, with sales of ₹53 Cr in March 2014, highlighting its expansion trajectory over the past decade.
Profitability and Efficiency Metrics
The profitability of Chemcon Speciality Chemicals is illustrated by its operating profit margin (OPM), which stood at 14.52% for the most recent reporting period. This margin reflects a decline from 32% in March 2022, indicating challenges in maintaining profitability amidst rising operational costs. The company’s net profit for March 2023 was ₹55 Cr, down from ₹63 Cr in the previous year, resulting in an earnings per share (EPS) of ₹15.04 for that period. The interest coverage ratio (ICR) was robust at 13.50x, suggesting that the company can comfortably meet its interest obligations. However, the return on equity (ROE) of 5% and return on capital employed (ROCE) of 7.01% are relatively low compared to industry standards, which typically range higher, indicating potential inefficiencies in capital utilization. The fluctuation in profitability metrics raises concerns, particularly as the company navigates a competitive and cost-sensitive market.
Balance Sheet Strength and Financial Ratios
Chemcon’s balance sheet is characterized by a strong position with total borrowings reported at ₹0 Cr, highlighting a debt-free status that enhances financial stability. Reserves have grown to ₹476 Cr, up from ₹421 Cr in the previous year, indicating the company’s ability to retain earnings and strengthen its equity base. The current ratio stood at 6.69, significantly above the typical industry benchmark of 1.5, suggesting that Chemcon can easily cover its short-term liabilities. Furthermore, the price-to-book value (P/BV) ratio is at 1.21x, reflecting a reasonable valuation relative to its net asset value, although this is lower than the sector average. The company also reported a cash conversion cycle (CCC) of 303 days, indicating longer operating cycles which could affect liquidity. Overall, while Chemcon exhibits strong balance sheet metrics, the high CCC may warrant attention given its implications for operational efficiency.
Shareholding Pattern and Investor Confidence
The shareholding structure of Chemcon Speciality Chemicals indicates a strong promoter commitment, with promoters holding 74.47% of the company’s equity. This significant stake suggests a stable governance framework and alignment of interests between management and shareholders. However, foreign institutional investors (FIIs) hold only 0.27%, reflecting limited external interest in the company. Domestic institutional investors (DIIs) have no stake, further indicating a potential lack of confidence among institutional investors. The total number of shareholders has declined from 86,831 in December 2022 to 69,211 by September 2025, suggesting a potential loss of retail investor interest. This trend may raise concerns about liquidity and market perception, as a concentrated ownership structure could lead to volatility in stock performance. The dynamics of shareholding could influence Chemcon’s ability to attract future investments, especially in a capital-intensive industry.
Outlook, Risks, and Final Insight
Looking ahead, Chemcon faces both opportunities and challenges. The company’s strong balance sheet and lack of debt position it favorably for potential investments in capacity expansion or new product development. However, persistent volatility in sales and declining profitability metrics pose significant risks. The projected decline in sales over the next two fiscal years may hinder growth prospects if not addressed through strategic initiatives. Additionally, the high cash conversion cycle indicates potential inefficiencies that need to be optimized to enhance liquidity. In scenarios where operational efficiencies are improved and market conditions stabilize, Chemcon could regain investor confidence and operational momentum. Conversely, failure to address declining margins and sales could lead to further erosion of market position and shareholder trust. The company must navigate these challenges carefully to sustain its growth trajectory in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 409 Cr. | 43.5 | 83.5/41.2 | 25.4 | 20.5 | 0.92 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.2 Cr. | 63.5 | 91.9/56.0 | 14.9 | 89.6 | 1.57 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 730 | 935/600 | 22.9 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,406 Cr. | 75.1 | 111/74.0 | 22.6 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 651 Cr. | 261 | 393/241 | 23.4 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,790.80 Cr | 727.35 | 71.44 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 89.41 | 57.92 | 76.47 | 79.08 | 79.33 | 75.19 | 52.98 | 59.59 | 45.52 | 52.60 | 54.39 | 54.89 | 53.52 |
| Expenses | 55.86 | 48.33 | 62.98 | 65.02 | 71.62 | 66.86 | 46.64 | 55.21 | 38.40 | 44.09 | 43.10 | 49.10 | 45.75 |
| Operating Profit | 33.55 | 9.59 | 13.49 | 14.06 | 7.71 | 8.33 | 6.34 | 4.38 | 7.12 | 8.51 | 11.29 | 5.79 | 7.77 |
| OPM % | 37.52% | 16.56% | 17.64% | 17.78% | 9.72% | 11.08% | 11.97% | 7.35% | 15.64% | 16.18% | 20.76% | 10.55% | 14.52% |
| Other Income | 2.68 | 3.29 | 4.46 | 2.89 | 3.59 | 3.03 | 3.34 | 3.34 | 3.76 | 3.50 | 4.01 | 3.18 | 3.72 |
| Interest | 0.16 | 0.25 | 0.59 | 0.49 | 0.68 | 0.73 | 1.04 | 1.05 | 0.99 | 0.93 | 0.74 | 0.84 | 0.34 |
| Depreciation | 1.93 | 2.05 | 2.14 | 2.26 | 2.62 | 2.59 | 2.58 | 2.51 | 2.53 | 2.55 | 2.71 | 2.73 | 2.72 |
| Profit before tax | 34.14 | 10.58 | 15.22 | 14.20 | 8.00 | 8.04 | 6.06 | 4.16 | 7.36 | 8.53 | 11.85 | 5.40 | 8.43 |
| Tax % | 25.42% | 25.99% | 25.36% | 26.27% | 26.25% | 26.12% | 26.73% | 30.05% | 27.17% | 25.79% | 25.74% | 26.85% | 24.20% |
| Net Profit | 25.46 | 7.82 | 11.36 | 10.47 | 5.91 | 5.94 | 4.44 | 2.90 | 5.37 | 6.33 | 8.81 | 3.95 | 6.39 |
| EPS in Rs | 6.95 | 2.13 | 3.10 | 2.86 | 1.61 | 1.62 | 1.21 | 0.79 | 1.47 | 1.73 | 2.41 | 1.08 | 1.74 |
Last Updated: August 20, 2025, 12:15 pm
Below is a detailed analysis of the quarterly data for Chemcon Speciality Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 53.52 Cr.. The value appears to be declining and may need further review. It has decreased from 54.89 Cr. (Mar 2025) to 53.52 Cr., marking a decrease of 1.37 Cr..
- For Expenses, as of Jun 2025, the value is 45.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 49.10 Cr. (Mar 2025) to 45.75 Cr., marking a decrease of 3.35 Cr..
- For Operating Profit, as of Jun 2025, the value is 7.77 Cr.. The value appears strong and on an upward trend. It has increased from 5.79 Cr. (Mar 2025) to 7.77 Cr., marking an increase of 1.98 Cr..
- For OPM %, as of Jun 2025, the value is 14.52%. The value appears strong and on an upward trend. It has increased from 10.55% (Mar 2025) to 14.52%, marking an increase of 3.97%.
- For Other Income, as of Jun 2025, the value is 3.72 Cr.. The value appears strong and on an upward trend. It has increased from 3.18 Cr. (Mar 2025) to 3.72 Cr., marking an increase of 0.54 Cr..
- For Interest, as of Jun 2025, the value is 0.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.84 Cr. (Mar 2025) to 0.34 Cr., marking a decrease of 0.50 Cr..
- For Depreciation, as of Jun 2025, the value is 2.72 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.73 Cr. (Mar 2025) to 2.72 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 8.43 Cr.. The value appears strong and on an upward trend. It has increased from 5.40 Cr. (Mar 2025) to 8.43 Cr., marking an increase of 3.03 Cr..
- For Tax %, as of Jun 2025, the value is 24.20%. The value appears to be improving (decreasing) as expected. It has decreased from 26.85% (Mar 2025) to 24.20%, marking a decrease of 2.65%.
- For Net Profit, as of Jun 2025, the value is 6.39 Cr.. The value appears strong and on an upward trend. It has increased from 3.95 Cr. (Mar 2025) to 6.39 Cr., marking an increase of 2.44 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.74. The value appears strong and on an upward trend. It has increased from 1.08 (Mar 2025) to 1.74, marking an increase of 0.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53 | 63 | 97 | 88 | 158 | 303 | 262 | 243 | 257 | 303 | 267 | 207 | 217 |
| Expenses | 46 | 56 | 87 | 79 | 112 | 237 | 192 | 162 | 175 | 232 | 240 | 174 | 185 |
| Operating Profit | 6 | 8 | 10 | 9 | 46 | 66 | 70 | 81 | 82 | 71 | 27 | 33 | 32 |
| OPM % | 12% | 12% | 10% | 10% | 29% | 22% | 27% | 33% | 32% | 23% | 10% | 16% | 15% |
| Other Income | 0 | -1 | 0 | 0 | 0 | 2 | 4 | 5 | 9 | 13 | 13 | 14 | 15 |
| Interest | 2 | 2 | 3 | 2 | 3 | 4 | 5 | 4 | 1 | 1 | 4 | 3 | 2 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 3 | 5 | 6 | 6 | 8 | 10 | 11 | 11 |
| Profit before tax | 3 | 3 | 5 | 5 | 41 | 61 | 65 | 76 | 84 | 74 | 26 | 33 | 34 |
| Tax % | 60% | 3% | 35% | 37% | 35% | 30% | 25% | 26% | 25% | 26% | 27% | 26% | |
| Net Profit | 1 | 3 | 3 | 3 | 26 | 43 | 49 | 56 | 63 | 55 | 19 | 24 | 25 |
| EPS in Rs | 1.46 | 3.35 | 4.09 | 3.78 | 33.21 | 13.54 | 15.37 | 15.40 | 17.13 | 15.04 | 5.24 | 6.67 | 6.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | 0.00% | 0.00% | 766.67% | 65.38% | 13.95% | 14.29% | 12.50% | -12.70% | -65.45% | 26.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | -200.00% | 0.00% | 766.67% | -701.28% | -51.43% | 0.33% | -1.79% | -25.20% | -52.76% | 91.77% |
Chemcon Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -5% |
| 3 Years: | -7% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | -13% |
| 3 Years: | -27% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -21% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | 7% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 1:55 am
Balance Sheet
Last Updated: December 10, 2025, 2:31 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 32 | 32 | 37 | 37 | 37 | 37 | 37 | 37 |
| Reserves | 11 | 13 | 16 | 19 | 46 | 65 | 115 | 317 | 381 | 421 | 440 | 464 | 476 |
| Borrowings | 14 | 12 | 13 | 20 | 17 | 33 | 46 | 6 | 36 | 64 | 43 | 25 | 0 |
| Other Liabilities | 12 | 10 | 9 | 15 | 27 | 43 | 34 | 44 | 45 | 32 | 26 | 29 | 35 |
| Total Liabilities | 45 | 44 | 46 | 63 | 97 | 173 | 226 | 404 | 498 | 553 | 545 | 554 | 548 |
| Fixed Assets | 20 | 20 | 19 | 24 | 30 | 40 | 49 | 67 | 82 | 141 | 146 | 149 | 144 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 9 | 34 | 14 | 42 | 40 | 47 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 11 |
| Other Assets | 25 | 24 | 27 | 38 | 67 | 133 | 173 | 328 | 382 | 398 | 356 | 355 | 346 |
| Total Assets | 45 | 44 | 46 | 63 | 97 | 173 | 226 | 404 | 498 | 553 | 545 | 554 | 548 |
Below is a detailed analysis of the balance sheet data for Chemcon Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 37.00 Cr..
- For Reserves, as of Sep 2025, the value is 476.00 Cr.. The value appears strong and on an upward trend. It has increased from 464.00 Cr. (Mar 2025) to 476.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 25.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 6.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 548.00 Cr.. The value appears to be improving (decreasing). It has decreased from 554.00 Cr. (Mar 2025) to 548.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 346.00 Cr.. The value appears to be declining and may need further review. It has decreased from 355.00 Cr. (Mar 2025) to 346.00 Cr., marking a decrease of 9.00 Cr..
- For Total Assets, as of Sep 2025, the value is 548.00 Cr.. The value appears to be declining and may need further review. It has decreased from 554.00 Cr. (Mar 2025) to 548.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (476.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -4.00 | -3.00 | -11.00 | 29.00 | 33.00 | 24.00 | 75.00 | 46.00 | 7.00 | -16.00 | 8.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 52 | 51 | 93 | 68 | 77 | 124 | 142 | 146 | 81 | 112 | 91 |
| Inventory Days | 146 | 74 | 45 | 58 | 99 | 91 | 118 | 175 | 102 | 164 | 119 | 261 |
| Days Payable | 97 | 79 | 39 | 81 | 82 | 57 | 63 | 67 | 70 | 44 | 23 | 49 |
| Cash Conversion Cycle | 89 | 47 | 57 | 70 | 86 | 111 | 179 | 250 | 177 | 201 | 208 | 303 |
| Working Capital Days | 85 | 64 | 59 | 8 | 61 | 59 | 135 | 184 | 105 | 108 | 162 | 211 |
| ROCE % | 17% | 17% | 22% | 16% | 74% | 65% | 43% | 29% | 21% | 15% | 6% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Resources & Energy Fund | 100,000 | 0.27 | 2.67 | 100,000 | 2025-04-22 17:25:38 | 0% |
| Tata Resources & Energy Fund - Direct Plan | 100,000 | 0.27 | 2.67 | 100,000 | 2025-04-22 17:25:38 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.68 | 5.24 | 15.04 | 17.13 | 16.48 |
| Diluted EPS (Rs.) | 6.68 | 5.24 | 15.04 | 17.13 | 16.48 |
| Cash EPS (Rs.) | 9.54 | 8.05 | 17.33 | 18.84 | 17.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 136.68 | 130.06 | 124.86 | 113.89 | 96.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 136.68 | 130.06 | 124.86 | 113.89 | 96.56 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 4.00 | 4.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 56.62 | 72.91 | 82.69 | 70.19 | 66.47 |
| PBDIT / Share (Rs.) | 12.87 | 10.94 | 22.93 | 24.80 | 23.41 |
| PBIT / Share (Rs.) | 10.00 | 8.12 | 20.65 | 23.09 | 21.75 |
| PBT / Share (Rs.) | 9.05 | 7.17 | 20.24 | 22.93 | 20.76 |
| Net Profit / Share (Rs.) | 6.67 | 5.24 | 15.04 | 17.13 | 15.40 |
| PBDIT Margin (%) | 22.73 | 15.00 | 27.73 | 35.32 | 35.22 |
| PBIT Margin (%) | 17.66 | 11.14 | 24.97 | 32.89 | 32.72 |
| PBT Margin (%) | 15.98 | 9.83 | 24.48 | 32.66 | 31.23 |
| Net Profit Margin (%) | 11.78 | 7.18 | 18.19 | 24.40 | 23.16 |
| Return on Networth / Equity (%) | 4.88 | 4.02 | 12.04 | 15.04 | 15.94 |
| Return on Capital Employeed (%) | 7.23 | 6.17 | 16.36 | 20.11 | 22.23 |
| Return On Assets (%) | 4.41 | 3.52 | 9.95 | 12.60 | 13.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.04 | 0.08 | 0.13 | 0.08 | 0.01 |
| Asset Turnover Ratio (%) | 0.37 | 0.48 | 0.57 | 0.57 | 0.77 |
| Current Ratio (X) | 6.69 | 5.54 | 3.41 | 4.84 | 6.30 |
| Quick Ratio (X) | 4.88 | 4.58 | 2.55 | 4.40 | 4.99 |
| Inventory Turnover Ratio (X) | 2.81 | 2.90 | 3.30 | 2.49 | 2.11 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 26.58 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 23.08 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 73.42 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 76.92 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 13.50 | 11.46 | 56.44 | 159.53 | 23.61 |
| Interest Coverage Ratio (Post Tax) (X) | 8.00 | 6.49 | 38.02 | 111.22 | 16.52 |
| Enterprise Value (Cr.) | 488.86 | 718.52 | 773.10 | 787.64 | 1372.68 |
| EV / Net Operating Revenue (X) | 2.36 | 2.69 | 2.55 | 3.06 | 5.64 |
| EV / EBITDA (X) | 10.37 | 17.93 | 9.20 | 8.67 | 16.00 |
| MarketCap / Net Operating Revenue (X) | 2.92 | 3.17 | 2.77 | 3.80 | 6.13 |
| Retention Ratios (%) | 0.00 | 0.00 | 73.41 | 0.00 | 0.00 |
| Price / BV (X) | 1.21 | 1.78 | 1.84 | 2.34 | 4.22 |
| Price / Net Operating Revenue (X) | 2.92 | 3.17 | 2.77 | 3.80 | 6.13 |
| EarningsYield | 0.04 | 0.02 | 0.06 | 0.06 | 0.03 |
After reviewing the key financial ratios for Chemcon Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.68. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 6.68, marking an increase of 1.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.68. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 6.68, marking an increase of 1.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.54. This value is within the healthy range. It has increased from 8.05 (Mar 24) to 9.54, marking an increase of 1.49.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.68. It has increased from 130.06 (Mar 24) to 136.68, marking an increase of 6.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.68. It has increased from 130.06 (Mar 24) to 136.68, marking an increase of 6.62.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 56.62. It has decreased from 72.91 (Mar 24) to 56.62, marking a decrease of 16.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has increased from 10.94 (Mar 24) to 12.87, marking an increase of 1.93.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has increased from 8.12 (Mar 24) to 10.00, marking an increase of 1.88.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 7.17 (Mar 24) to 9.05, marking an increase of 1.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 6.67, marking an increase of 1.43.
- For PBDIT Margin (%), as of Mar 25, the value is 22.73. This value is within the healthy range. It has increased from 15.00 (Mar 24) to 22.73, marking an increase of 7.73.
- For PBIT Margin (%), as of Mar 25, the value is 17.66. This value is within the healthy range. It has increased from 11.14 (Mar 24) to 17.66, marking an increase of 6.52.
- For PBT Margin (%), as of Mar 25, the value is 15.98. This value is within the healthy range. It has increased from 9.83 (Mar 24) to 15.98, marking an increase of 6.15.
- For Net Profit Margin (%), as of Mar 25, the value is 11.78. This value exceeds the healthy maximum of 10. It has increased from 7.18 (Mar 24) to 11.78, marking an increase of 4.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 15. It has increased from 4.02 (Mar 24) to 4.88, marking an increase of 0.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 7.23. This value is below the healthy minimum of 10. It has increased from 6.17 (Mar 24) to 7.23, marking an increase of 1.06.
- For Return On Assets (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 5. It has increased from 3.52 (Mar 24) to 4.41, marking an increase of 0.89.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.04, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.37. It has decreased from 0.48 (Mar 24) to 0.37, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 6.69. This value exceeds the healthy maximum of 3. It has increased from 5.54 (Mar 24) to 6.69, marking an increase of 1.15.
- For Quick Ratio (X), as of Mar 25, the value is 4.88. This value exceeds the healthy maximum of 2. It has increased from 4.58 (Mar 24) to 4.88, marking an increase of 0.30.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 4. It has decreased from 2.90 (Mar 24) to 2.81, marking a decrease of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.50. This value is within the healthy range. It has increased from 11.46 (Mar 24) to 13.50, marking an increase of 2.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.00. This value is within the healthy range. It has increased from 6.49 (Mar 24) to 8.00, marking an increase of 1.51.
- For Enterprise Value (Cr.), as of Mar 25, the value is 488.86. It has decreased from 718.52 (Mar 24) to 488.86, marking a decrease of 229.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.36. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 2.36, marking a decrease of 0.33.
- For EV / EBITDA (X), as of Mar 25, the value is 10.37. This value is within the healthy range. It has decreased from 17.93 (Mar 24) to 10.37, marking a decrease of 7.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.92. This value is within the healthy range. It has decreased from 3.17 (Mar 24) to 2.92, marking a decrease of 0.25.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.78 (Mar 24) to 1.21, marking a decrease of 0.57.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.92. This value is within the healthy range. It has decreased from 3.17 (Mar 24) to 2.92, marking a decrease of 0.25.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chemcon Speciality Chemicals Ltd:
- Net Profit Margin: 11.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.23% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.88% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.7 (Industry average Stock P/E: 71.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.78%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Block No 355, Manjusar Kinpad Road, Vadodra Gujarat 391775 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kamalkumar Rajendra Aggarwal | Chairman & Managing Director |
| Mr. Naresh Vijaykumar Goyal | Joint Managing Director |
| Mr. Rajesh Chimanlal Gandhi | WholeTime Director & CFO |
| Mr. Himanshu Prafulchandra Purohit | Whole Time Director |
| Mr. Navdeep Naresh Goyal | Whole Time Director |
| Mr. Rajveer Kamal Aggarwal | Non Exe.Non Ind.Director |
| Mr. Bharat Chunilal Shah | Independent Director |
| Mrs. Neelu Atulkumar Shah | Independent Director |
| Mr. Lalit Ramniklal Mehta | Independent Director |
| Mr. Pankaj Amritlal Shah | Independent Director |
| Mr. Ketan Bhailal Shah | Independent Director |
| Mr. Neel Snehalkumar Shah | Independent Director |
FAQ
What is the intrinsic value of Chemcon Speciality Chemicals Ltd?
Chemcon Speciality Chemicals Ltd's intrinsic value (as of 24 December 2025) is 169.65 which is 15.60% lower the current market price of 201.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 741 Cr. market cap, FY2025-2026 high/low of 295/160, reserves of ₹476 Cr, and liabilities of 548 Cr.
What is the Market Cap of Chemcon Speciality Chemicals Ltd?
The Market Cap of Chemcon Speciality Chemicals Ltd is 741 Cr..
What is the current Stock Price of Chemcon Speciality Chemicals Ltd as on 24 December 2025?
The current stock price of Chemcon Speciality Chemicals Ltd as on 24 December 2025 is 201.
What is the High / Low of Chemcon Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chemcon Speciality Chemicals Ltd stocks is 295/160.
What is the Stock P/E of Chemcon Speciality Chemicals Ltd?
The Stock P/E of Chemcon Speciality Chemicals Ltd is 29.7.
What is the Book Value of Chemcon Speciality Chemicals Ltd?
The Book Value of Chemcon Speciality Chemicals Ltd is 140.
What is the Dividend Yield of Chemcon Speciality Chemicals Ltd?
The Dividend Yield of Chemcon Speciality Chemicals Ltd is 0.00 %.
What is the ROCE of Chemcon Speciality Chemicals Ltd?
The ROCE of Chemcon Speciality Chemicals Ltd is 7.01 %.
What is the ROE of Chemcon Speciality Chemicals Ltd?
The ROE of Chemcon Speciality Chemicals Ltd is 5.00 %.
What is the Face Value of Chemcon Speciality Chemicals Ltd?
The Face Value of Chemcon Speciality Chemicals Ltd is 10.0.